This activity is supported by independent medical education grants from Regeneron Pharmaceuticals and Carl Zeiss Meditec.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education
Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Anton Orlin, MD
Associate Professor of Ophthalmology
Weill Cornell Medical College
New York, NY
D. Wilkin Parke III, MD
VitreoRetinal Surgery, PA
Co-director, Vitreoretinal Surgery Fellowship Program
Minneapolis, MN
Aleksandra V. Rachitskaya, MD
Assistant Professor of Ophthalmology
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Camila Ventura, MD, PhD
Department of Ophthalmology
Retina Specialist
Department of Research, Director
Altino Ventura Foundation (FAV)
Hope Eye Hospital
Recife, Pernambuco, Brazil
Valentina Franco Cárdenas, MD
Medical and Surgical Retina Specialist
Mexico City, Mexico
James C. Major Jr MD, PhD, FACS
Retina Consultants of Houston
Assistant Professor
Weill Cornell Medical College
Blanton Eye Institute
Houston Methodist Hospital
Houston, TX
Cynthia Qian, MD, FRCSC, DABO
Assistant Professor of Clinical Ophthalmology
Vice President, Canadian Retina Society
Director, Pediatric Retina Service
Director, Retinal Dystrophy Service and the Electrophysiology Laboratories
University of Montreal
Montréal, Québec, Canada
Nathan Steinle, MD
California Retina Consultants
Santa Barbara, CA
Jeremy Wolfe, MD, MS
Associate Professor of Ophthalmolgy Oakland University William Beaumont School of Medicine
Partner, Associated Retinal Consultants
Co-Director, Vitreoretinal Fellowship Program
Royal Oak, MI
FELLOWS
Pablo Chamartin, MD
APEC (Asociación para Evitar la Ceguera en México)
David Ta Kim, MD
University of Toronto – St. Michael’s Hospital
Idaira Sanchez Santos, MD
APEC (Asociación para Evitar la Ceguera en México)
Jay C. Wang, MD
Massachusetts Eye and Ear
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Moderators
Anton Orlin, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, and Carl Zeiss Meditec.
Wilkin Parke III, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Royalties: Vortex Surgical.
Aleksandra V. Rachitskaya, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, and Carl Zeiss Meditec. Speaker’s Bureau: Novartis.
Camila Ventura, MD, PhD has no financial relationships with commercial interests.
Panelists
Valentina Franco Cárdenas, MD has no financial relationships with commercial interests.
James C. Major Jr MD, PhD, FACS has no financial relationships with commercial interests.
Cynthia Qian, MD, FRCSC, DABO and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bayer and Novartis.
Nathan Steinle, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Appellis, Genentech, Novartis, Regeneron Pharmaceuticals, and REGENXBIO. Grant/Research Support: Carl Zeiss Meditec, and Ocular Therapeutix. Speaker’s Bureau: Genentech, Novartis, and Regeneron Pharmaceuticals. Stock/Shareholder: Vortex Surgical.
Jeremy Wolfe, MD, MS and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Genentech, and Novartis. Grant/Research: Genentech, Kodiak, Novartis, and Regeneron Pharmaceuticals. Speaker’s Bureau: Allergan, Genentech, Novartis, and Regeneron Pharmaceuticals. Stock/Shareholder: Vortex Surgical
Fellows
Pablo Chamartin, MD; David Ta Kim, MD; Idaira Sanchez Santos, MD; Jay C. Wang, MD; have no financial relationships with commercial interests.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.